Novel JNK Inhibitor Molecules
- 专利权人:
- XIGEN S.A.
- 发明人:
- Christophe BONNY
- 申请号：
- US14614337
- 公开号：
- US20150266923A1
- 申请日:
- 2015.02.04
- 申请国别(地区):
- US
- 年份:
- 2015
- 代理人:
- 摘要：
- The present invention relates to novel JNK inhibitor molecules. The present invention furthermore relates to methods for raising antibodies against such INK inhibitor molecules as well as to the respective antibodies and cells producing said antibodies.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- BIOCOMPATIBLE IMPLANTS COMPRISING ENGINEERED ENDOTHELIAL CELLS
- GENETICALLY MODIFIED NK-92 CELLS WITH DECREASED CD96/TIGIT EXPRESSION
- METHODS FOR ENHANCING ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY
- CELLULES NKT A CD1D RESTREINT EN TANT QUE PLATEFORME POUR L'IMMUNOTHERAPIE ANTICANCEREUSE EN VENTE LIBRE
- NKT CELL ACTIVATION PHARMACEUTICAL COMPOSITION, PRODUCTION METHOD THEREFOR, AND PRESERVATION METHOD FOR ANTIGEN-PRESENTING CELLS
